- XNAS Volume
XNAS 21 Feb, 2025 4:30 PM (EST)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 1,907 | 22,873 | - | - | Restricted Stock Units | |
| Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 1,907 | 2,232 | - | - | Common Stock | |
| Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Feb 2025 | 1,107 | 142,900 | - | 0 | Common Stock | |
| Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Feb 2025 | 1,107 | 325 | - | 0 | Common Stock | |
| Andrew Spaventa | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.89 per share. | 12 Feb 2025 | 800 | 1,432 | - | 19.9 | 15,912 | Common Stock |
| Eli Glezer | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2025 | 500 | 155,583 | - | - | Common Stock | |
| Eli Glezer | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2025 | 500 | 6,000 | - | - | Restricted Stock Units | |
| Dalen Meeter | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2025 | 500 | 9,502 | - | - | Common Stock | |
| Dalen Meeter | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2025 | 500 | 6,000 | - | - | Restricted Stock Units | |
| Jyotsna Ghai | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2025 | 250 | 3,283 | - | - | Common Stock | |
| Jyotsna Ghai | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2025 | 250 | 3,000 | - | - | Restricted Stock Units | |
| Jyotsna Ghai | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 417 | 3,033 | - | - | Common Stock | |
| Jyotsna Ghai | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 417 | 4,583 | - | - | Restricted Stock Units | |
| Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 486 | 811 | - | - | Common Stock | |
| Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 486 | 4,374 | - | - | Restricted Stock Units | |
| Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Dec 2024 | 306 | 141,793 | - | 0 | Common Stock | |
| Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Dec 2024 | 306 | 325 | - | 0 | Common Stock | |
| Andrew Spaventa | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 20.16 per share. | 15 Dec 2024 | 180 | 631 | - | 20.2 | 3,629 | Common Stock |
| Eli Glezer | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 250 | 2,250 | - | - | Restricted Stock Units | |
| Eli Glezer | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 250 | 155,083 | - | - | Common Stock | |
| Dalen Meeter | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 209 | 9,002 | - | - | Common Stock | |
| Dalen Meeter | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 209 | 1,874 | - | - | Restricted Stock Units | |
| Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2024 | 1,212 | 325 | - | 0 | Common Stock | |
| Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2024 | 1,907 | 2,232 | - | - | Common Stock | |
| Andrew Spaventa | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 22.55 per share. | 12 Nov 2024 | 695 | 1,537 | - | 22.5 | 15,669 | Common Stock |
| Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2024 | 1,907 | 24,780 | - | - | Restricted Stock Units | |
| Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2024 | 1,212 | 141,487 | - | 0 | Common Stock | |
| Eli Glezer | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2024 | 500 | 6,500 | - | - | Restricted Stock Units | |
| Eli Glezer | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2024 | 500 | 154,833 | - | - | Common Stock | |
| Dalen Meeter | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2024 | 500 | 6,500 | - | - | Restricted Stock Units | |
| Dalen Meeter | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2024 | 500 | 8,693 | - | - | Common Stock | |
| Jyotsna Ghai | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2024 | 250 | 3,250 | - | - | Restricted Stock Units | |
| Jyotsna Ghai | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2024 | 250 | 2,516 | - | - | Common Stock | |
| Jyotsna Ghai | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2024 | 1,666 | 2,266 | - | - | Common Stock | |
| Jyotsna Ghai | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2024 | 1,666 | 5,000 | - | - | Restricted Stock Units | |
| Andrew Spaventa | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 12.38 per share. | 15 Sep 2024 | 175 | 637 | - | 12.4 | 2,167 | Common Stock |
| Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Sep 2024 | 312 | 140,275 | - | 0 | Common Stock | |
| Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Sep 2024 | 312 | 325 | - | 0 | Common Stock | |
| Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2024 | 487 | 812 | - | - | Common Stock | |
| Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2024 | 487 | 4,860 | - | - | Restricted Stock Units | |
| Eli Glezer | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2024 | 250 | 2,500 | - | - | Restricted Stock Units | |
| Eli Glezer | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2024 | 250 | 154,333 | - | - | Common Stock | |
| Dalen Meeter | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2024 | 209 | 2,083 | - | - | Restricted Stock Units | |
| Dalen Meeter | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2024 | 209 | 8,193 | - | - | Common Stock | |
| Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2024 | 1,906 | 2,231 | - | - | Common Stock | |
| Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2024 | 1,906 | 26,687 | - | - | Restricted Stock Units | |
| Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Aug 2024 | 1,225 | 139,963 | - | 0 | Common Stock | |
| Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Aug 2024 | 1,225 | 325 | - | 0 | Common Stock | |
| Andrew Spaventa | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.12 per share. | 12 Aug 2024 | 681 | 1,550 | - | 7.1 | 4,849 | Common Stock |
| Eli Glezer | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2024 | 500 | 154,083 | - | - | Common Stock | |
| Eli Glezer | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2024 | 500 | 7,000 | - | - | Restricted Stock Units | |
| Dalen Meeter | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2024 | 500 | 7,984 | - | - | Common Stock | |
| Dalen Meeter | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2024 | 500 | 7,000 | - | - | Restricted Stock Units | |
| Jyotsna Ghai | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2024 | 250 | 600 | - | - | Common Stock | |
| Jyotsna Ghai | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2024 | 250 | 3,500 | - | - | Restricted Stock Units | |
| Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Jun 2024 | 14,584 | 4,162,144 | - | 0 | Common Stock | |
| Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 14,584 | 160,416 | - | - | Restricted Stock Units | |
| Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Jun 2024 | 14,584 | 9,766 | - | 0 | Common Stock | |
| Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 14,584 | 24,350 | - | - | Common Stock | |
| Eli Glezer | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 7,500 | 4,607,500 | - | - | Common Stock | |
| Eli Glezer | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 7,500 | 82,500 | - | - | Restricted Stock Units | |
| Dalen Meeter | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 6,250 | 68,750 | - | - | Restricted Stock Units | |
| Dalen Meeter | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 6,250 | 224,523 | - | - | Common Stock | |
| David L. Barker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 74,000 | 74,000 | - | - | Stock Option (Right to Buy) | |
| Elaine R. Mardis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 74,000 | 74,000 | - | - | Stock Option (Right to Buy) | |
| Michael J. Pellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Jason Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 74,000 | 74,000 | - | - | Stock Option (Right to Buy) | |
| Kim P. Kamdar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 74,000 | 74,000 | - | - | Stock Option (Right to Buy) | |
| Marcia Eisenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 55,500 | 55,500 | - | - | Stock Option (Right to Buy) | |
| Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2024 | 57,188 | 857,812 | - | - | Restricted Stock Units | |
| Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2024 | 57,188 | 66,954 | - | - | Common Stock | |
| Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 12 May 2024 | 57,188 | 9,766 | - | 0 | Common Stock | |
| Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 12 May 2024 | 57,188 | 4,147,560 | - | 0 | Common Stock | |
| Eli Glezer | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2024 | 15,000 | 225,000 | - | - | Restricted Stock Units | |
| Eli Glezer | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2024 | 15,000 | 4,600,000 | - | - | Common Stock | |
| Dalen Meeter | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2024 | 15,000 | 215,273 | - | - | Common Stock | |
| Dalen Meeter | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2024 | 15,000 | 225,000 | - | - | Restricted Stock Units | |
| Jyotsna Ghai | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2024 | 7,500 | 10,500 | - | - | Common Stock | |
| Jyotsna Ghai | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2024 | 7,500 | 112,500 | - | - | Restricted Stock Units | |
| Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 14,583 | 24,349 | - | - | Common Stock | |
| Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Mar 2024 | 14,583 | 4,090,372 | - | 0 | Common Stock | |
| Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Mar 2024 | 14,583 | 9,766 | - | 0 | Common Stock | |
| Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 14,583 | 175,000 | - | - | Restricted Stock Units | |
| Eli Glezer | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 7,500 | 90,000 | - | - | Restricted Stock Units | |
| Eli Glezer | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 7,500 | 4,585,000 | - | - | Common Stock | |
| Dalen Meeter | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 6,250 | 200,273 | - | - | Common Stock | |
| Dalen Meeter | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 6,250 | 75,000 | - | - | Restricted Stock Units | |
| Samuel Ropp | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 4,187 | 50,250 | - | - | Restricted Stock Units | |
| Samuel Ropp | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 4,187 | 16,750 | - | - | Common Stock | |
| Spaventa Andrew | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 915,000 | 915,000 | - | - | Restricted Stock Unit | |
| Dalen Meeter | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 240,000 | 240,000 | - | - | Restricted Stock Unit | |
| Jyotsna Ghai | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 120,000 | 120,000 | - | - | Restricted Stock Unit | |
| Samuel Ropp | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 200,000 | 200,000 | - | - | Restricted Stock Unit | |
| Eli Glezer | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 240,000 | 240,000 | - | - | Restricted Stock Unit | |
| Dalen Meeter | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 6,250 | 81,250 | - | - | Restricted Stock Units | |
| Glezer Eli | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 7,500 | 97,500 | - | - | Restricted Stock Units | |
| Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Dec 2023 | 14,583 | 4,075,789 | - | 0 | Common Stock | |
| Spaventa Andrew | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 14,583 | 189,583 | - | - | Restricted Stock Units | |
| Spaventa Andrew | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Dec 2023 | 14,583 | 9,766 | - | 0 | Common Stock | |
| Samuel Ropp | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 4,188 | 12,563 | - | - | Common Stock | |
| Eli Glezer | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 7,500 | 4,577,500 | - | - | Common Stock | |
| Spaventa Andrew | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 14,583 | 24,349 | - | - | Common Stock | |
| Samuel Ropp | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 4,188 | 54,437 | - | - | Restricted Stock Units | |
| Meeter Dalen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 6,250 | 194,023 | - | - | Common Stock | |
| Samuel Ropp | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Samuel Ropp | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Kim P. Kamdar | Director | Sale of securities on an exchange or to another person at price $ 0.53 per share. | 11 Aug 2023 | 200,000 | 3,763,985 | - | 0.5 | 106,960 | Common Stock |
| Kim P. Kamdar | Director | Sale of securities on an exchange or to another person at price $ 0.57 per share. | 11 Aug 2023 | 77,991 | 3,963,985 | - | 0.6 | 44,424 | Common Stock |
| Kim P. Kamdar | Director | Sale of securities on an exchange or to another person at price $ 0.60 per share. | 11 Aug 2023 | 353,657 | 4,041,976 | - | 0.6 | 210,603 | Common Stock |
| Marcia Eisenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2023 | 148,000 | 148,000 | - | - | Stock Option (Right to Buy) | |
| Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 14,583 | 218,750 | - | - | Restricted Stock Units | |
| Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 14,583 | 24,349 | - | - | Common Stock | |
| Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Jun 2023 | 14,583 | 9,766 | - | 0 | Common Stock | |
| Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Jun 2023 | 14,583 | 3,928,154 | - | 0 | Common Stock | |
| Eli Glezer | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 7,500 | 4,362,500 | - | - | Common Stock | |
| Eli Glezer | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 7,500 | 112,500 | - | - | Restricted Stock Units | |
| Dalen Meeter | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 6,250 | 93,750 | - | - | Restricted Stock Units | |
| Dalen Meeter | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 6,250 | 181,521 | - | - | Common Stock | |
| Samuel Ropp | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 4,188 | 62,812 | - | - | Restricted Stock Units | |
| Samuel Ropp | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 4,188 | 4,188 | - | - | Common Stock | |
| David L. Barker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 74,000 | 74,000 | - | - | Stock Option (Right to Buy) | |
| Elaine R. Mardis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 74,000 | 74,000 | - | - | Stock Option (Right to Buy) | |
| Michael J. Pellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Jason Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 74,000 | 74,000 | - | - | Stock Option (Right to Buy) | |
| Kim P. Kamdar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 74,000 | 74,000 | - | - | Stock Option (Right to Buy) | |
| Eli Glezer | Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 0.82 per share. | 17 May 2023 | 170,000 | 4,355,000 | - | 0.8 | 138,924 | Common Stock |
| Andrew Spaventa | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 466,667 | 466,667 | - | - | Employee Stock Option (right to buy) | |
| Andrew Spaventa | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 233,333 | 233,333 | - | - | Restricted Stock Unit | |
| Eli Glezer | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 240,000 | 240,000 | - | - | Employee Stock Option (right to buy) | |
| Eli Glezer | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 120,000 | 120,000 | - | - | Restricted Stock Unit | |
| Dalen Meeter | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 200,000 | 200,000 | - | - | Employee Stock Option (right to buy) | |
| Dalen Meeter | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 100,000 | 100,000 | - | - | Restricted Stock Unit | |
| Michael J. Pellini | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 72,455 | 26,834 | - | 0 | Common Stock | |
| Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 500,000 | 3,913,571 | - | 0 | Common Stock | |
| Eli Glezer | Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 2.00 per share. | 12 Dec 2022 | 50,000 | 4,185,000 | - | 2 | 100,000 | Common Stock |
| David L. Barker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2022 | 60,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| David L. Barker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.63 per share. | 07 Jul 2022 | 60,000 | 60,000 | - | 0.6 | 37,800 | Common Stock |
| Michael J. Pellini | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.21 per share. | 31 May 2022 | 60,668 | 159,957 | - | 0.2 | 12,789 | Common Stock |
| Michael J. Pellini | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 31 May 2022 | 34,271 | 194,228 | - | 0.2 | 8,054 | Common Stock |
| Michael J. Pellini | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.63 per share. | 31 May 2022 | 60,000 | 254,228 | - | 0.6 | 37,800 | Common Stock |
| Michael J. Pellini | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 May 2022 | 154,939 | 99,289 | - | 0 | Common Stock | |
| Michael J. Pellini | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2022 | 60,668 | 0 | - | - | Stock Option (Right to Buy) | |
| Michael J. Pellini | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2022 | 34,271 | 0 | - | - | Stock Option (Right to Buy) | |
| Michael J. Pellini | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2022 | 60,000 | 0 | - | - | Stock Option (Right to Buy) | |
| David L. Barker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 46,250 | 46,250 | - | - | Stock Option (Right to Buy) | |
| Elaine R. Mardis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 19,271 | 19,271 | - | - | Stock Option (Right to Buy) | |
| Michael J. Pellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 62,500 | 62,500 | - | - | Stock Option (Right to Buy) | |
| Jason Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 46,250 | 46,250 | - | - | Stock Option (Right to Buy) | |
| Kim P. Kamdar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 46,250 | 46,250 | - | - | Stock Option (Right to Buy) | |
| Michael J. Pellini | Director | Purchase of securities on an exchange or from another person at price $ 3.30 per share. | 18 May 2022 | 26,834 | 99,289 | - | 3.3 | 88,552 | Common Stock |
| Andrew Spaventa | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 24 Mar 2022 | 9,766 | 9,766 | - | - | Common Stock | |
| Andrew Spaventa | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 24 Mar 2022 | 173,144 | 0 | - | - | Common Stock | |
| David J. Daly | President and Chief Operating | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 125,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| David J. Daly | President and Chief Operating | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 125,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Andrew Spaventa | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 1,000,000 | 1,000,000 | - | - | Employee Stock Option (right to buy) | |
| Eli Glezer | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 500,000 | 500,000 | - | - | Employee Stock Option (right to buy) | |
| Dalen Meeter | Senior Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 187,500 | 187,500 | - | - | Employee Stock Option (right to buy) | |
| Elaine R. Mardis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Andrew Spaventa | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 02 Dec 2021 | 715,884 | 173,144 | - | - | Common Stock | |
| Michael J. Pellini | Director | 01 Jun 2021 | 96,944 | 96,944 | - | - | Common Stock | ||
| Michael J. Pellini | Director | 01 Jun 2021 | 96,944 | 0 | - | - | Series A Preferred Stock | ||
| Kim P. Kamdar | Director | 01 Jun 2021 | 1,293,243 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Kim P. Kamdar | Director | 01 Jun 2021 | 2,666,781 | 0 | - | - | Series Seed Convertible Preferred Stock | ||
| Kim P. Kamdar | Director | 01 Jun 2021 | 4,395,633 | 4,495,633 | - | - | Common Stock | ||
| Kim P. Kamdar | Director | 01 Jun 2021 | 435,609 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Andrew Spaventa | Director, Chief Executive Officer | 01 Jun 2021 | 173,144 | 0 | - | - | Convertible Promissory Note | ||
| Andrew Spaventa | Director, Chief Executive Officer | 01 Jun 2021 | 173,144 | 889,028 | - | 17.6 | 3,047,334 | Common Stock | |
| Andrew Spaventa | Director, Chief Executive Officer | 01 Jun 2021 | 715,884 | 715,884 | - | - | Common Stock | ||
| Andrew Spaventa | Director, Chief Executive Officer | 01 Jun 2021 | 362,266 | 0 | - | - | Series Seed Preferred Stock | ||
| Andrew Spaventa | Director, Chief Executive Officer | 01 Jun 2021 | 152,463 | 0 | - | - | Series B Preferred Stock | ||
| Andrew Spaventa | Director, Chief Executive Officer | 01 Jun 2021 | 201,155 | 0 | - | - | Series A Preferred Stock | ||
| Dalen Meeter | Senior Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 50,000 | 50,000 | - | - | Employee Stock Option |